A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Clinical trial NCT04039503 · COMPLETED
Trial details
- NCT number
- NCT04039503
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-30
- Primary completion
- 2020-12-22
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.